PTA balloon catheters combine angioplasty with targeted injection
system in a single device for use in below the knee procedures.
WAYNE, Pa.--(BUSINESS WIRE)--Jul. 29, 2014--
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical
devices for critical care and surgery, has announced that its subsidiary
Hotspur Technologies, Inc. received FDA 510(k) clearance to market the
Arrow® GPSCath® Balloon Dilatation Catheters designed for use with .014”
guide wires and in 150 cm length. These novel products enable a variety
of peripheral vascular procedures to be performed below the knee with
one dual function catheter, potentially reducing procedure time,
radiation dosage, and expense for both patients and medical
professionals.
The Arrow® GPSCath® Balloon Dilatation Catheter is the first dual
functional balloon dilatation catheter that combines angioplasty with
the proprietary VisioValve™ Injection System. This innovative
combination enables physicians to perform peripheral below the knee
angioplasty and inject physician selected fluids, such as contrast
media, while maintaining guide wire position.
“With this latest product approval we continue our commitment to
enabling medical professionals to perform peripheral access procedures
that simplify and improve the doctor and patient experience while
reducing health care costs,” said Benson Smith, Chairman, President &
CEO of Teleflex. Added Smith, “We are excited to bring this innovative
product for use in below the knee peripheral interventions to the
market.”
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical devices for a
range of procedures in critical care and surgery. Our mission is to
provide solutions that enable healthcare providers to improve outcomes
and enhance patient and provider safety. Headquartered in Wayne, PA,
Teleflex employs approximately 11,400 people worldwide and serves
healthcare providers in more than 150 countries. Additional information
about Teleflex can be obtained from the company's website at teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
Teleflex, GPSCath, Hotspur and VisioValve are trademarks or
registered trademarks of Teleflex Incorporated or its affiliates. © 2014
Teleflex Incorporated. All rights reserved. MC-000259
Source: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice
President, Investor Relations
610-948-2836
jake.elguicze@teleflex.com
www.teleflex.com